Sign in
4

Changes in Ownership

Karyopharm Therapeutics Inc. Filed Acc 0000950170-24-017237

EVP, Chief Development Officer sold 5,847 shares at an average $1.33 ($7,783)

From the SEC's structured data for this filing

Trades in this filing

Poulton Stuart · EVP, Chief Development Officer

Table I: Non-derivative

2 lines
Date Transaction Shares Price Value Owned after D/I
2024-02-15 Sale : show line 1 in the form −5,748 $1.33 $7,645 163,871 D
2024-02-15 Sale : show line 2 in the form −99 $1.40 $139 163,772 D
Open-market sales · 5,847 sh · avg $1.33 · $7,783
Loading xslF345X05/ownership.xml…